DarioHealth Corp. $DRIO Shares Sold by Phoenix Financial Ltd.

Phoenix Financial Ltd. reduced its position in DarioHealth Corp. (NASDAQ:DRIO) by 95.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 56,337 shares of the company’s stock after selling 1,070,399 shares during the quarter. Phoenix Financial Ltd.’s holdings in DarioHealth were worth $977,000 as of its most recent filing with the Securities and Exchange Commission.

Separately, XTX Topco Ltd increased its stake in DarioHealth by 229.0% during the second quarter. XTX Topco Ltd now owns 62,511 shares of the company’s stock worth $42,000 after acquiring an additional 43,513 shares during the last quarter. 33.39% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have recently weighed in on DRIO. TD Cowen reaffirmed a “hold” rating on shares of DarioHealth in a research note on Friday, November 14th. Stifel Nicolaus set a $16.00 price target on shares of DarioHealth in a report on Friday, November 14th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DarioHealth in a research report on Monday, December 29th. Finally, Wall Street Zen lowered shares of DarioHealth from a “hold” rating to a “sell” rating in a research report on Sunday. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $32.00.

DarioHealth Price Performance

Shares of DRIO stock opened at $10.91 on Wednesday. DarioHealth Corp. has a twelve month low of $5.93 and a twelve month high of $17.74. The company has a market capitalization of $73.72 million, a PE ratio of -0.98 and a beta of 1.05. The company has a current ratio of 4.55, a quick ratio of 4.02 and a debt-to-equity ratio of 0.41. The firm has a fifty day simple moving average of $11.89 and a 200-day simple moving average of $11.93.

DarioHealth Company Profile

DarioHealth (NASDAQ:DRIO) is a digital health company specializing in chronic disease management through a smartphone-based care platform. Its core solution combines connected devices—such as glucose meters, blood pressure monitors and smart scales—with real-time data analytics and personalized coaching. The platform is designed to support individuals living with diabetes, hypertension, weight management challenges and other cardiometabolic conditions, offering continuous monitoring, tailored insights and behavioral nudges aimed at improving clinical outcomes.

The Dario platform integrates artificial intelligence and machine learning to deliver personalized guidance and education.